{"title":"众议院听证会以证人反对芬太尼法案结束","authors":"Alison Knopf","doi":"10.1002/adaw.34410","DOIUrl":null,"url":null,"abstract":"<p>A February 6 hearing by the House Energy and Commerce Committee, Subcommittee on Health focused on fentanyl. Despite recommendations by two physicians and a university professor against doing so, the full House passed the HALT Fentanyl Act later that day. Congressman Brett Guthrie (R-Kentucky), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter (Georgia-R), chairman Subcommittee on Health, sponsored the bill, which passed by a vote of 312 to 108.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 7","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"House hearing ends with fentanyl bill witnesses recommended against\",\"authors\":\"Alison Knopf\",\"doi\":\"10.1002/adaw.34410\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A February 6 hearing by the House Energy and Commerce Committee, Subcommittee on Health focused on fentanyl. Despite recommendations by two physicians and a university professor against doing so, the full House passed the HALT Fentanyl Act later that day. Congressman Brett Guthrie (R-Kentucky), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter (Georgia-R), chairman Subcommittee on Health, sponsored the bill, which passed by a vote of 312 to 108.</p>\",\"PeriodicalId\":100073,\"journal\":{\"name\":\"Alcoholism & Drug Abuse Weekly\",\"volume\":\"37 7\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alcoholism & Drug Abuse Weekly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34410\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alcoholism & Drug Abuse Weekly","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/adaw.34410","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
House hearing ends with fentanyl bill witnesses recommended against
A February 6 hearing by the House Energy and Commerce Committee, Subcommittee on Health focused on fentanyl. Despite recommendations by two physicians and a university professor against doing so, the full House passed the HALT Fentanyl Act later that day. Congressman Brett Guthrie (R-Kentucky), Chairman of the House Committee on Energy and Commerce, and Congressman Earl L. “Buddy” Carter (Georgia-R), chairman Subcommittee on Health, sponsored the bill, which passed by a vote of 312 to 108.